Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Helius Medical Technologies, Inc. (NASDAQ: HSDT).

Full DD Report for HSDT

You must become a subscriber to view this report.


Recent News from (NASDAQ: HSDT)

Helius Medical Technologies to Present at the 12th Annual Canaccord Medical Technologies & Diagnostics Forum
NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the 12th Annual Canacc...
Source: GlobeNewswire
Date: November, 01 2018 16:05
Helius Announces First Partnership to Implement Clinical Experience Programs With the Investigational PoNS(TM) Therapy in the United States
NEWTOWN, Pa., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it has partnered with The Ohio State University Wexn...
Source: GlobeNewswire
Date: September, 19 2018 07:00
Your Daily Scoop: Recro Proceeds, MannKind Zooms, Aduro's Publication
News in focus: REPH, MNKD Recro Pharma plans to resubmit NDA Discussion : On September 4, Recro Pharma ( REPH ) reported positive outcome of its meeting with the FDA regarding its NDA for IV meloxicam that was rejected in last May. Based on the discussion with the FDA, the comp...
Source: SeekingAlpha
Date: September, 07 2018 16:31
Helius Medical Technologies to Participate in the 20th Annual Global Investment Conference Sponsored by Rodman & Renshaw and H.C. Wainwright & Co.
NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced it will be featured as a presenting company at the 20th A...
Source: GlobeNewswire
Date: September, 04 2018 16:05
Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS(TM) Device
NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company has submitted a request to the U.S. Food...
Source: GlobeNewswire
Date: September, 04 2018 07:00
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2018 Annual Shareholder Meeting
NEWTOWN, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (Nasdaq:HSDT) (“ Helius ” or the “ Company ”) announced today the results of the matters submitted for voting at the annual meeting of shareholders (“ Annual Meetin...
Source: GlobeNewswire
Date: July, 23 2018 07:01
Helius Medical Technologies, Inc. Names Jennifer Laux as Chief Commercialization Officer
NEWTOWN, Pa., July 12, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, is pleased to announce the appointment of Jennifer Laux as Chief Commercia...
Source: GlobeNewswire
Date: July, 12 2018 17:16
Helius Medical Technologies, Inc. Announces MRI Confirmatory Evidence of Neuroplastic Change after Investigational PoNS(TM) Treatment Presented at the 2018 Joint Annual Meeting ISMRM - ESMRMB in Paris, France
NEWTOWN, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that an important paper, “ Gray matter volume chang...
Source: GlobeNewswire
Date: June, 28 2018 07:01
Advancing Neurostimulation Therapies for Optical Deficiencies Impacting Healthcare Industry in a Billion Dollar Way
Palm Beach, FL – (June 27, 2018) — According to a recent report issued by Transparency Market Research, the global neurology devices market is projected to hit a value of $13.6 billion in 2019, coupled with a very impressive growth rate.  Neurological devices available in th...
Source: MarketNewsUpdates.com
Date: June, 27 2018 08:11
Global Neurological Devices Market to Rise and Hit $13.6 Billion in 2019
An evolution in how we treat and rehabilitate our neuro pathways is underway. According to a new report, the global neurology devices market is projected to hit a value of $13.6 billion in 2019 , coupled with a very impressive growth rate. With the rise comes deeper investment into cutting-e...
Source: Livemoney
Date: June, 25 2018 10:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1811.3310.9211.3310.8616,869
2018-05-1711.3310.9211.3310.8616,869

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1047,39762,58775.7298Short
2018-12-077,60224,54430.9729Cover
2018-12-065,20013,92237.3510Short
2018-12-0416,68431,82952.4176Short
2018-12-0315,17019,39078.2362Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HSDT.


About Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Logo for Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Helius Medical Technologies Inc., is engaged primarily in the medical technology industry focused on neurological wellness. The Company s planned principal operations include the development, licensing and acquisition of unique and non invasive platform technologies to amplify the brain s ability to heal itself. The Company s first product in development, known as the portable neuromodulation stimulator or PoNS therapy platform, is designed to enhance the brain s ability to compensate for this damage. The PoNS therapy is a combination of a powerful, wearable, direct current stimulation device, and functional, targeted therapy, and is currently being developed for the treatment of movement, gait and balance disorders in patients with traumatic brain injury and other chronic neurological diseases

 

Contact Information

 

 

Current Management

  • Philippe Deschamps / President, CEO
  • Joyce LaViscount / CFO, COO
  • Kofi Berantuo / Contact Person
  • Dane Andreeff / Director
    • Mr. Andreeff, age , is the general partner and portfolio manager of Maple Leaf Partners, LP, a long/short value hedge fund, a position he has held since . Mr. Andreeff also serves as a member of the board of directors of TraceSecurity, LLC, HDL Therapeutics, Inc. and Myocardial Solutions, Ltd. Mr. Andreeff received his Bachelor s degree in Economics from the University of Texas at Arlington in and his Master s degree in Economics from the University of Texas at Arlington in . Our Board believes that Mr. Andreeff s extensive experience in the investment industry and capital markets will make him a valuable member of the Board.
  • Philippe Deschamps /
  • Thomas N. Griffin /
  • Huaizheng Peng /
  • Edward Straw /
  • Mitchell Tyler /
  • Blane Walter /

Current Share Structure

  • Market Cap: $224,559,200 - 03/16/2018
  • Issue and Outstanding: 20,241,135 - 03/05/2018

 


Recent Filings from (NASDAQ: HSDT)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 04 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Amendment to a previously filed SC TO-I
Filing Type: SC TO-I/AFiling Source: edgar
Filing Date: August, 09 2018
Tender offer schedule and amendment filed by the issuer
Filing Type: SC TO-IFiling Source: edgar
Filing Date: July, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 05 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: May, 29 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018

 

 


Daily Technical Chart for (NASDAQ: HSDT)

Daily Technical Chart for (NASDAQ: HSDT)


Stay tuned for daily updates and more on (NASDAQ: HSDT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: HSDT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HSDT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of HSDT and does not buy, sell, or trade any shares of HSDT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/